SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-008004
Filing Date
2017-11-02
Accepted
2017-11-02 16:06:35
Documents
96
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q irwd-20170930x10q.htm 10-Q 2546829
2 EX-31.1 irwd-20170930ex311e2123b.htm EX-31.1 18563
3 EX-31.2 irwd-20170930ex3128e189c.htm EX-31.2 18590
4 EX-32.1 irwd-20170930ex32139f654.htm EX-32.1 8497
5 EX-32.2 irwd-20170930ex32284d128.htm EX-32.2 8712
  Complete submission text file 0001558370-17-008004.txt   10614631

Data Files

Seq Description Document Type Size
6 EX-101.INS irwd-20170930.xml EX-101.INS 2399651
7 EX-101.SCH irwd-20170930.xsd EX-101.SCH 77109
8 EX-101.CAL irwd-20170930_cal.xml EX-101.CAL 82674
9 EX-101.DEF irwd-20170930_def.xml EX-101.DEF 420440
10 EX-101.LAB irwd-20170930_lab.xml EX-101.LAB 632019
11 EX-101.PRE irwd-20170930_pre.xml EX-101.PRE 636662
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-34620 | Film No.: 171172287
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences